CAS 1141397-80-9
:Cedazuridine
Description:
Cedazuridine, also known by its chemical name, is a nucleoside analog that functions primarily as an inhibitor of cytidine deaminase, an enzyme that degrades cytidine and its analogs. This characteristic enhances the bioavailability and efficacy of certain chemotherapeutic agents, particularly in the treatment of cancer. Cedazuridine is often used in combination with other drugs to improve their therapeutic effects while reducing toxicity. The compound is typically administered orally and is known for its role in enhancing the pharmacokinetics of nucleoside analogs, allowing for lower doses and potentially fewer side effects. Its mechanism of action involves the prevention of the conversion of cytidine to uridine, thereby increasing the levels of active nucleoside analogs in the body. Cedazuridine has been studied in various clinical settings, particularly in hematological malignancies, and continues to be an area of interest in cancer research for its potential to improve treatment outcomes.
- (R)-1-((2R, 4R, SR)-3,3-difluoro-4-hydroxy (hydroxymethyl) tetrahydrofuran-2-yl)-4-hydroxytetrahydropyrimidin-2(1H)-one
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
Cedazuridine
CAS:Cedazuridine ((4R)-2'-Deoxy-2',2'-difluoro-3,4,5,6-tetrahydrouridine) is an oral inhibitor of cytidine deaminase with antineoplastic properties.Formula:C9H14F2N2O5Purity:99.66%Color and Shape:SolidMolecular weight:268.21
